Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Anemic Patients
20%
Associated Complications
20%
Associated Costs
20%
Avian Influenza
20%
Bleeding
60%
Bleeding Patients
20%
Bleeding Prophylaxis
20%
Blood Inventory
20%
Blood Products
20%
Blood Shortage
20%
Cardiac Surgery
100%
Cardiac Surgical Patients
20%
Chemical Inactivation
20%
Coagulation
20%
Coagulation Factors
20%
Critical Organ
20%
Disease Prevention
20%
Excessive Bleeding
40%
Factor Level
20%
Fibrinolysis
20%
First-line Therapy
20%
Health Care Costs
20%
Hemostatic Function
20%
Heparin
20%
Hypoperfusion
20%
Immune Regulation
20%
Increased Incidence
20%
Inventory Cost
20%
Lifesaving
20%
New Intervention
20%
Operative Time
20%
Optimal Management
100%
Organ System
20%
Overall Health
20%
Pathogen Inactivation
20%
Pathophysiology
20%
Patient Safety
20%
Patients at Risk
20%
Pharmacologic Agents
20%
POC Diagnostics
40%
Postoperative Bleeding
100%
Potential Pathogens
20%
Randomized Controlled Trial
20%
Rapid Acquisition
20%
Re-exploration
20%
Recombinant Activated Factor VII (rFVIIa)
20%
Risk Management
100%
Sporadic CJD
20%
Surgical Bleeding
20%
Transfusion
100%
Transfusion Complications
20%
Transfusion Medicine
20%
Transfusion Risks
100%
Transfusion-related Acute Lung Injury (TRALI)
20%
Medicine and Dentistry
Avian Influenza Virus
16%
Bleeding
100%
Blood Clotting Factor
16%
Blood Product
16%
Creutzfeldt-Jakob Disease
16%
Fibrinolysis
16%
Health Care Cost
33%
Heart Surgery
100%
Hemostat
16%
Heparin
16%
Immunomodulation
16%
Leukocyte
16%
Operative Blood Loss
16%
Organ Systems
16%
Pathogen
33%
Pathophysiology
16%
Patient Safety
16%
Randomized Controlled Trial
16%
Sequela
16%
Severe Acute Respiratory Syndrome
16%
Transfusion Medicine
16%
Transfusion Related Acute Lung Injury
16%